Obizur Kit
Product Images NDC 0944-5001

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Obizur (NDC 0944-5001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Obizur 01)

An instructional illustration showing a hand holding a vial, with an arrow indicating the direction to pull or remove the vial cap. This image likely demonstrates a step in the preparation or administration process for the OBIZUR kit.*

FDA Label Image

Figure B (Obizur 02)

An instructional line drawing showing a pair of hands opening a vial or small container, illustrating the initial step in preparing a medication kit. The image suggests manipulation of a cap or stopper, commonly associated with reconstituting or accessing a drug product.*

FDA Label Image

Figure C (Obizur 03)

An instructional diagram showing a pair of hands holding a syringe. The illustration emphasizes a back-and-forth motion indicated by a bi-directional arrow, suggesting mixing or agitation of the syringe contents, likely related to preparation or reconstitution for the OBIZUR Antihemophilic Factor (Recombinant) kit by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Figure D (Obizur 04)

An instructional illustration showing a hand holding a syringe above a vial or container, with arrows indicating to insert or attach the syringe and to push the plunger, suggesting steps in preparing or drawing medication from the vial in the OBIZUR kit.*

FDA Label Image

Figure E (Obizur 05)

An instructional illustration showing a hand drawing liquid from a vial using a syringe, with another hand holding the vial and a cap placed nearby. The image appears to demonstrate a step in medication preparation or administration, associated with the OBIZUR kit by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Figure F (Obizur 06)

An instructional illustration showing a hand holding a vial and another hand inserting a syringe needle into the vial's stopper, with a downward arrow indicating the motion to push the needle down. The image is related to the use or preparation of a medication kit, likely for OBIZUR, Antihemophilic Factor (Recombinant), Porcine Sequence.*

FDA Label Image

Figure G (Obizur 07)

An instructional illustration showing a hand holding a syringe and inserting the needle into a vial, with arrows indicating the direction for twisting or turning. The image likely demonstrates the preparation or mixing step of the OBIZUR kit by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Figure H (Obizur 08)

An instructional diagram showing two hands preparing a medication kit. One hand is holding a vial and pulling a cap off, while the other hand holds a bottle, indicating removal of the cap or stopper. The image likely demonstrates a preparation step for the OBIZUR kit by Takeda Pharmaceuticals America.*

FDA Label Image

Figure I (Obizur 09)

An instructional illustration showing a hand holding a syringe with a plunger being pulled downward. The image indicates the action of drawing liquid into the syringe, as emphasized by a large black arrow pointing down along the syringe barrel.*

FDA Label Image

Principal Display Panel (Kit Carton)

The image shows the packaging label for OBIZUR, a kit containing Antihemophilic Factor (Recombinant), Porcine Sequence. The label includes the product name, dosage form as a single-dose vial, and a 500 units range. It mentions intravenous administration after reconstitution and provides storage and handling instructions. The labeler is Takeda Pharmaceuticals America, Inc., with references to Baxalta US Inc. and the Shire logo, indicating manufacturer and licensing details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.